AxoTect
Atlanta
About AxoTect
AxoTect, is a biopharmaceutical company, intends to develop AxoTect, Inc. small-molecule drugs for the treatment of pain associated with Chemotherapy induced peripheral neuropathy (CPIN).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Nov 2007)
Industries & Categories
Biopharma, Biotechnology, Health Diagnostics
Canonical: https://fsome.com/organization/axotect-3171084 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.